Wolfgang Miesbach: Therapeutic Potential of Protein S Inhibition in Glanzmann Thrombasthenia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Rim Diab et al, published in ASH, adding:
“Honored to have attended last weekend’s EHA‑SWG Scientific Meeting on Bleeding and Platelet Disorders, where Rim Diab from the Anne Angelillo-Scherrer group presented her inspiring work on ‘Enhancing Hemostasis in Glanzmann Thrombasthenia via Protein S Inhibition.’
I particularly appreciated how she concluded by reminding us that Glanzmann himself was a Swiss pediatrician who first described this rare platelet disorder in 1918 during his tenure at the Children’s Hospital in Bern, Switzerland — beautifully linking the roots of the disease to today’s one of the most exciting haemostasis research.”
Title: Enhancing hemostasis in glanzmann thrombasthenia via protein S inhibition
Authors: Rim Diab, Tanja Knopp, Mathieu Fiore, Sonia Avoue-celerier, Léonard Julien Simon Schacher, Raja Prince-Eladnani, Anne Angelillo-Scherrer
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Jul 23, 2026, 10:33Johanna Rodríguez: The Structural Challenge of Next-Gen Anticoagulants
-
Jul 23, 2026, 10:27Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT
-
Jul 23, 2026, 09:05Fonkou Steve: What If We’ve Been Asking the Wrong Question About Plasma Too?
-
Jul 23, 2026, 08:27Registration Is Now Open for ASH 2026
-
Jul 23, 2026, 08:19Sheeza Nawaz: Why Do Patients With Aortic Stenosis Bleed?
-
Jul 23, 2026, 07:59Paschalis Karakasis: Can Left Atrial Appendage Closure Truly Replace Oral Anticoagulation?
-
Jul 23, 2026, 06:53Lakmali Silva: What Makes ISTH More Than a Scientific Meeting?
-
Jul 23, 2026, 05:48Paschalis Evangelidis: Rethinking Pulmonary Embolism Through the Lens of Thromboinflammation
-
Jul 23, 2026, 05:35Neil Morgan: Honoured to Lead the Platelet and Megakaryocyte Theme at ISTH 2026